Qwell Pharma Raises $7 Million
Qwell Pharmaceuticals, a Seattle-based drug developer focused on tumors and excess inflammation of skin cells, has raised $7 million in Series A funding, according to Xconomy. Arch Venture Partners and the Wellcome Trust co-led the round.
7 January 2009•1 min read
